AR020741A1 - Composicion y metodo para tratar enfermedades alergicas - Google Patents

Composicion y metodo para tratar enfermedades alergicas

Info

Publication number
AR020741A1
AR020741A1 ARP990105083A ARP990105083A AR020741A1 AR 020741 A1 AR020741 A1 AR 020741A1 AR P990105083 A ARP990105083 A AR P990105083A AR P990105083 A ARP990105083 A AR P990105083A AR 020741 A1 AR020741 A1 AR 020741A1
Authority
AR
Argentina
Prior art keywords
composition
allergic diseases
treat allergic
effective amount
treat
Prior art date
Application number
ARP990105083A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR020741A1 publication Critical patent/AR020741A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP990105083A 1998-10-09 1999-10-07 Composicion y metodo para tratar enfermedades alergicas AR020741A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16960998A 1998-10-09 1998-10-09

Publications (1)

Publication Number Publication Date
AR020741A1 true AR020741A1 (es) 2002-05-29

Family

ID=22616408

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105083A AR020741A1 (es) 1998-10-09 1999-10-07 Composicion y metodo para tratar enfermedades alergicas

Country Status (9)

Country Link
EP (1) EP1119372A1 (fr)
JP (1) JP2002527406A (fr)
CN (1) CN1329505A (fr)
AR (1) AR020741A1 (fr)
AU (1) AU6391199A (fr)
CA (1) CA2346228A1 (fr)
CO (1) CO5140080A1 (fr)
PE (1) PE20001095A1 (fr)
WO (1) WO2000021564A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004229507B2 (en) * 2003-04-15 2008-12-18 Merck Frosst Canada & Co. Polymorphic form of montelukast sodium
ATE481968T1 (de) * 2004-07-14 2010-10-15 Inflammation Res Ct Company Lt Verfahren zur hemmung von tumormetastasierung
EP2117538A1 (fr) 2007-01-24 2009-11-18 Glaxo Group Limited Compositions pharmaceutiques contenant du 2-méthoxy-5- (5-trifluorométhyl-tétrazol-i-yl-benzyl) - (2s-phényl-pipéridin-3s-yl-)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9415997D0 (en) * 1994-08-08 1994-09-28 Merck Sharp & Dohme Therapeutic agents
ATE532530T1 (de) * 1994-12-12 2011-11-15 Omeros Corp Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und/oder spasmen an einer gefässstruktur
GB9521781D0 (en) * 1995-10-24 1996-01-03 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
PE20001095A1 (es) 2000-10-31
JP2002527406A (ja) 2002-08-27
WO2000021564A1 (fr) 2000-04-20
CN1329505A (zh) 2002-01-02
CO5140080A1 (es) 2002-03-22
EP1119372A1 (fr) 2001-08-01
AU6391199A (en) 2000-05-01
CA2346228A1 (fr) 2000-04-20

Similar Documents

Publication Publication Date Title
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
DE69529912D1 (de) Verwendung des sekretorischen leukozytaren protease inhibitors (slpi) als tryptase-inhibitor
MY134110A (en) Combinations of reboxetine and neuroleptic agents
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
BR0311375A (pt) Composição farmacêutica, uso da mesma, e, método para o tratamento de demência ou dano cognitivo suave em um mamìfero
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
EP1007556A4 (fr) Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
EP1769797A3 (fr) Procédés et compositions utilisant de la cétirizine en combinaison avec des inhibiteurs de leucotriène pour le traitement des affections répondant à l'inhibition des leucotriènes
AR025923A1 (es) Nueva combinacion de loteprednol y antihistaminicos
CY1106800T1 (el) Μεθοδοι και συνθεσεις δια χρησιμοποιησεως μεταβολιτων τepφεναδινης εν συνδυασμω μετ’ αναστολεων λευκοτριενιου
AR020740A1 (es) Composicion y metodo para tratar enfermedades alergicas
BR0214643A (pt) Aplicação de um antagonista h1, e um esteróide seguro para tratar rinite
ME00549B (me) Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
AR020741A1 (es) Composicion y metodo para tratar enfermedades alergicas
WO2003051290A3 (fr) Traitement de maladies mediees par les lymphocytes b par modulation de l'activite du dr6
PA8552301A1 (es) Metodo para el tratamiento de insomnio primario
BG106748A (en) Method and compositions for treating pulmonary diseases
ECSP993167A (es) Composicion y metodo para tratar enfermedades alergicas
ECSP993168A (es) Composicion y metodo para tratar enfermedades alergicas
NO20053247D0 (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.
AU2003259198A8 (en) Method and composition for treating and preventing influenza infection and symptoms thereof
WO2000054770A8 (fr) Compositions pharmaceutiques renfermant des sous-unites de troponine, ou des fragments ou des homologues desdites sous-unites, et leur utilisation pour inhiber l'angiogenese
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite

Legal Events

Date Code Title Description
FB Suspension of granting procedure